Universal Familial Hypercholesterolemia Screening in Children

Status Completed

Clinical Trial Summary

30 million individuals globally with undiagnosed familial hypercholesterolemia (FH) are at a substantial cardiovascular disease (CVD) risk, which could be normalized by early diagnosis and treatment. Effective screening strategies are urgently needed, but the data on universal FH screening (uFHs) is scarce. The investigators aim to assess the overall performance of the uFHs program in Slovenia and to compare the common elements to the pilot uFHs program in Lower Saxony (LS; Germany).

Clinical Trial Description

The study will include pediatric patients (or their siblings and parents in Slovenian cohort) undergoing the universal hypercholesterolemia screening; those with elevated cholesterol at universal cholesterol screening at primary care level are referred to the lipidology specialist at the UMC Ljubljana (Slovenia) or Kinderkrankenhaus auf der Bult (Lower Saxony, Germany). For those with elevated cholesterol levels, the familial hypercholesterolemia genetic diagnostics is done centrally in UMC Ljubljana. Only those will be included from whom a signed informed consent by themselves or by their parents/guardians will be obtained prior to the genetic diagnosis of familial hypercholesterolemia. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04507984
Study type	Observational [Patient Registry]
Source	University of Ljubljana, Faculty of Medicine
Contact
Status	Completed
Phase
Start date	January 1, 2019
Completion date	December 31, 2021

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT05284513` - Collaborative Approach to Reach Everyone With Familial Hypercholesterolemia (CARE-FH)	N/A
Enrolling by invitation	`NCT05271305` - Pilot Study for a National Screening for Familial Hypercholesterolemia
Completed	`NCT02750527` - Pediatric Population Screening for Type 1 Diabetes and Familial Hypercholesterolemia in Lower Saxony, Germany
Not yet recruiting	`NCT00924339` - Soy Food Intervention Trial	N/A
Withdrawn	`NCT00751608` - Effect of APL180 on Endothelial Function in Familial Hypercholesterolemia Patients	Phase 2
Terminated	`NCT00079846` - Implitapide in Patients With Homozygous Familial Hypercholesterolemia (HoFH) on Maximal Concurrent Lipid-Lowering Therapy	Phase 2
Completed	`NCT02624869` - Safety, Tolerability and Efficacy of Evolocumab (AMG 145) in Children With Inherited Elevated Low-density Lipoprotein Cholesterol (Familial Hypercholesterolemia)	Phase 3
Recruiting	`NCT05758779` - The Danish Familial Hypercholesterolemia Organized Coronary Screening Trial	N/A
Enrolling by invitation	`NCT04929457` - Evaluation of a Digiphysical Screening Method to Identify and Diagnose Familial Hypercholesterolemia
Not yet recruiting	`NCT04455581` - A Study to Determine the Safety, Tolerability, and Efficacy of SHR-1209 in Patients With Familial Hypercholesterolemia	Phase 2
Recruiting	`NCT04101149` - Genetic Causes of Familial Hypercholesterolemia
Completed	`NCT00943306` - Long Term, Follow-on Study of Lomitapide in Patients With Homozygous Familial Hypercholesterolemia	Phase 3
Completed	`NCT02462655` - Effects of LDL Apheresis System on the Expression of Genes Involved in Lipoprotein Metabolism and Inflammation in Homozygotes for Familial Hypercholesterolemia	N/A
Terminated	`NCT00079859` - Implitapide in Patients With Heterozygous Familial Hypercholesterolemia (HeFH) on Maximal Concurrent Lipid-Lowering Therapy	Phase 2
Recruiting	`NCT05066932` - Advanced Lipoproptein Profiling and Cardiovascular Risk Stratification in Familial Hypercholesterolemia
Not yet recruiting	`NCT04958629` - A Prospective Cohort Study on Familial Hypercholesterolemia in Health Examination Population
Completed	`NCT02709850` - Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS ANGPTL3-LRx in Healthy Volunteers With Elevated Triglycerides and Participants With Familial Hypercholesterolemia	Phase 1
Active, not recruiting	`NCT03832985` - Pediatric Reporting of Adult-Onset Genomic Results	Early Phase 1
Terminated	`NCT02013713` - French Observatory of Familial Hypercholesterolemia in Cardiology
Recruiting	`NCT02009345` - Familial Hypercholesterolemia Canada / Hypercholesterolemie Familiale Canada